Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Marco Ruella, Jakub Svoboda et al.|Nature Medicine|2022Cited by 308
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsAlex Ganetsky, David Porter, Jennifer Han et al.|Clinical Infectious Diseases|2018Cited by 79
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tractAlex Ganetsky, David Porter, Noelle V. Frey et al.|Bone Marrow Transplantation|2018Cited by 48
Risk of invasive fungal infections in patients with <scp>high‐risk MDS</scp> and <scp>AML</scp> receiving hypomethylating agentsGee Youn Kim, Alison W. Loren, Jonathan K. Burns et al.|American Journal of Hematology|2020Cited by 28
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamideCraig W. Freyer, Alison W. Loren, Alison Carulli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 10